Posttransplant lymphoproliferative disorders in lung transplant patients: The cleveland clinic experience

Modern Pathology

Volumn 15, Issue 6, 2002, Pages 647-656

  Ramalingam, P ^a   Rybicki, L ^a   Smith, M D ^a   Abrahams, N A ^a   Tubbs, R R ^a   Pettay, J ^a   Farver, C F ^a   Hsi, E D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; EXPERIENCE; FEMALE; HUMAN; IMMUNOPHENOTYPING; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MOLECULAR GENETICS; MONITORING; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT;

ADULT; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD30; ANTIGENS, CD43; ANTIGENS, CD79; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; RNA, VIRAL; SIALOGLYCOPROTEINS; SURVIVAL RATE;

EID: 0036082569     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880581     Document Type: Article

References (39)

1. Primary malignancy in patients undergoing immunosuppression for renal transplantation
2. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients
3. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression
4. The diagnosis and treatment of posttransplant lymphoproliferative disorders
5. Post-transplant lymphoproliferative disorders: A morphologfc, phenotypic and genotypic spectrum of disease
6. Classification of the posttransplant lymphoproliferative disorders: From the past to the present
7. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
8. The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation
9. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus
10. Epstein-Barrvirus-carrying lymphoma in cardiac transplant recipient
11. Clinical and pathological features of posttransplant lymphoproliferative disorders (PTLD)
12. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression
13. Molecular genetic analysis of lymphoid tumors arising after organ transplantation
14. Clonal characteristics of posttransplant lymphoproliferative disorders
15. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
16. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome
17. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients
18. Posttransplant lymphoproliferative disorders in renal allograft recipients: Report of 53 cases of a French multicenter study
19. Posttransplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center
20. PTLD in liver transplant recipients
21. CMV and EBV-PTLD after liver transplantation
22. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients
23. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation
24. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient
25. Cutaneous presentation of posttransplant lymphoproliferative disorder
26. The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting
27. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997
28. Molecular diagnosis of Epstein-Barr virus-related diseases
29. Post-transplant malignancy: The role of immunosuppression
30. Pretransplantation assessment of the risk of lymphoproliferative disorder
31. Cancers complicating organ transplantation
32. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: Primary presentation in the allograft
33. Malignant lymphoma in transplanted renal pelvis
34. Host origin of lymphomas in organ transplant recipients
35. Brief report: Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver
36. Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms
37. OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: A possible cause of lymphoproliferative disorders associated with transplantation
38. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers
39. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas